Evidence map›Paper›PMID 40051112›Full record

ArticleWater science and technology : a journal of the International Association on Water Pollution Research2022

Coke-oven wastewater treatment in a dual-chamber microbial fuel cell with thiocyanate-degrading biofilm enriched at the air cathode.

Kaho Yamada, Toshikazu Fukushima, Stefano Freguia

Abstract read
PubMed Publisher
In one paragraph

Article in Water science and technology : a journal of the International Association on Water Pollution Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kaho YamadaAdvanced Technology Research Laboratories, Research & Development, Nippon Steel Corporation, Futtsu, Japan E-mail: yamada.6er.kaho@jp.nipponsteel.com.ORCID https://orcid.org/0000-0003-2880-5540
Toshikazu FukushimaAdvanced Technology Research Laboratories, Research & Development, Nippon Steel Corporation, Futtsu, Japan.
Stefano FreguiaDepartment of Chemical Engineering, The University of Melbourne, Parkville, VIC 3010, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coke-oven wastewater is usually treated with the activated sludge process, which requires large amounts of electrical energy for aeration and sludge disposal. A more sustainable treatment is strongly required. Recently, microbial fuel cells (MFCs) are focused as a technology for the production of electricity from wastewaters with simultaneous removal of organic matter. However, no MFC has been reported that can remove phenol, thiosulfate and thiocyanate simultaneously without aeration. Phenol can generally be removed well, whereas thiocyanate is relatively difficult to degrade. In this study, a dual-chamber MFC (D-MFC) was designed and equipped with a thiocyanate-degrading biofilm enriched on an air cathode. The D-MFC degraded phenol and thiosulfate in the anode chamber at the rate of 104 and 331 mg/L/day, respectively and subsequently degraded thiocyanate in the cathode chamber at the rate of 250 mg/L/day. The D-MFC showed high thiocyanate degradation rate. This suggests that pre-enrichment could accelerate thiocyanate degradation in MFC. In addition, thiocyanate degradation was not inhibited by phenol as thiocyanate was removed in the cathode chamber after phenol was removed in the anode chamber. This study demonstrated the feasibility of treating coke-oven wastewater by a D-MFC with a thiocyanate-degrading biofilm enriched at the air cathode.

Indexed as

coke-oven wastewatermicrobial fuel cellphenol degradationthiocyanate degradation

Identifiers

PMID40051112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.